Boston Scientific CorpCyberattack disrupts global operations and IT systems, impairing order processing and adding to regulatory risks.

Boston Scientific has reported a major cyberattack that is disrupting its global operations and access to key IT systems, impairing its ability to process customer orders worldwide. The incident is ongoing, and the company has activated its incident response protocol to restore affected systems. Boston Scientific, a US medical equipment company with a market cap of about $72.3 billion, supplies devices used across interventional medical specialties, and any disruption to its IT systems can affect support for hospitals and clinicians. The attack challenges the company's efficiency-driven growth narrative, which relies on supply chain initiatives, digitalization, and manufacturing automation, and adds to existing regulatory risks such as product recalls. However, the attack does not directly affect the clinical case for products like FARAPULSE and WATCHMAN, leaving the key question of how quickly Boston Scientific can harden its systems to prevent recurring cyber risks from dragging on margins.
Boston Scientific CorpCyberattack disrupts global operations and IT systems, impairing order processing and adding to regulatory risks.